IFN-τ exhibits potent suppression of human papillomavirus E6/E7 oncoprotein expression

Journal of Interferon and Cytokine Research

Volumn 19, Issue 10, 1999, Pages 1107-1116

  Johnson, Jeffrey A ^a,c   Hochkeppel, Heinz Kurt ^b   Gangemi, J David ^a  

^a CLEMSON UNIVERSITY   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; TAU INTERFERON;

ARTICLE; CYTOKINE PRODUCTION; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WART VIRUS;

ANTIVIRAL AGENTS; CELL DIVISION; CELL LINE, TRANSFORMED; DEPRESSION, CHEMICAL; GENE EXPRESSION REGULATION, VIRAL; HUMANS; INTERFERON ALFA-2A; INTERFERON TYPE I; KERATINOCYTES; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PREGNANCY PROTEINS; REPRESSOR PROTEINS; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; OVIS;

EID: 0032692771     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099313046     Document Type: Article

References (40)

1. PETO, R. (1986). Introduction: geographic patterns and trends. In: Viral Etiology of Cervical Cancer. R. Peto and H. ZurHausen (eds.) Cold Spring Harbor, NY: CSH Laboratory, pp. 3-15.
2. BOSCH, F.X., MANOS, M., MUÑOS, N., SHERMAN, M., JANSEN, A.M., PETO, J., SHIFFMAN, M.H., MORENO, V., KURMAN, R., and SHAH, K.V. (1995). Prevalence of human papillomavirus in cervical carcinoma: a worldwide perspective. J. Natl. Cancer Inst. 87, 796-802.
3. LÖRINCZ, A.T., REID, R., JENSON, A.B., GREENBERG, M.D., LANCASTER, W., and KURMAN, R.J. (1992). Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet. Gynecol. 79, 328-337.
4. KOUTSKY, L.A., HOLMES, K.K., CRITCHLOW, C.W., STEVENS, C.E., PAAVONEN, J., BECKMANN, A.M., DEROUEN, T.A., GALLOWAY, D.A., VERNON, D., and KIVIAT, N.B. (1992). A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N. Engl J. Med. 327, 1272-1278.
5. VOUSDEN, K.H. (1994). Interactions between papillomavirus proteins and tumor suppressor gene products. Adv. Cancer Res. 64, 1-24.
6. HUIBREGESTE, J.M., SCHEFFNE, R.M., and HOWLEY, P.M. (1993). Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol. Cell Biol. 13, 4918-4927.
7. SHAW, P., BOVEY, R., TARDY, S., SAHLI, R., SORDAT, B., and COSTA, J. (1992). Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA 89, 4495-4499.
8. HOLT, S.E., GOLLAHON, L.S., WILLINGHAM, T., BARBOSA, M.S., and SHAY, J.W. (1996). p53 levels in human mammary epithelial cells expressing wild-type and mutant human papillomavirus type 16 (HPV-16) E6 proteins-relationship to reactivation of telomerase and immortalization. Int. J. Oncol. 8, 263-270.
9. KILNGELHUTZ, A.J., FOSTER, S.A., and McDOUGALL, J.K. (1996). Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380, 79-81.
10. ANTINORE, M.J., BIRRER, M.J., PATEL, D., NADER, L., and McCANCE, D.J. (1996). The human papillomavirus type 16 E7 gene product interacts with and transactivates the AP-1 family of transcription factors. EMBO J. 15, 1950-1960.
11. GANGEMI, J.D., PIRISI, L., ANGELL, M., and KREIDER, J.W. (1994). HPV replication in experimental models: effects of interferon. Antiviral Res. 24, 175-190.
12. BALKWILL, F.R. (1986). Animal models for investigating antitumor effects of interferon. Methods Enzymol. 119, 649-657.
13. IWASAKA, T., HAYASHI, Y., YOKOYAMA, M., HACHISUGA, T., and SUGIMORE, H. (1990). Interferon gamma treatment for cervical intraepithelial neoplasia. Gynecol. Oncol. 37, 96-102.
14. AIBA, H., and SHARON, N. (1986). Immunohistologic analysis of the phenomenon of spontaneous regression of numerous flat warts. Cancer 58, 1246-1251.
15. BORNSTEIN, J., BEN-DAVID, Y., ATAD, J., PASCAL, B., REVEL, M., and ABRAMOVICI, H. (1993). Treatment of cervical intraepithelial neoplasia and invasive squamous cell carcinoma by interferon. Obstet. Gynecol. Surv. 4504, 252-260.
16. WALDER, S., BURK, R.D., NEUBERG, D., RAMEAU, R., RUNOWICZ, C.D., GOLDBERG, G., McGILL, F., TACHEZY, R., COMIS, R., EDMONSON, J., and WIERNIK, P. (1995). Lack of efficacy of interferon-α therapy in recurrent, advanced cervical cancer. J. Interferon Cytokine Res. 15, 1011-1016.
17. MEISTER, A., UZÉ, G., MOGENSEN, K.E., GREDDER, I., TOVEY, M.G., GRÜTTER, M., and MEYER, F. (1986). Biological activities and receptor binding of two human recombinant interferons and their hybrids. J. Gen. Virol. 67, 1633-1643.
18. HOCHKEPPEL, H.-K., GRUETTER, M., HORISBERGER, M.A., and LAZDINS, J.K. (1992). Human IFN-alpha hybrids. Drugs Fut. 17, 899-614.
19. GANGEMI, J.D., LAZDINS, J., DIETRICH, F.M., MATTER, A., PONCIONI, B., and HOCHKEPPEL, H.-K. (1989). Antiviral activity of a novel recombinant human interferon-αB/D hybrid. J. Interferon Res. 9, 227-237.
20. KHAN, M.A., TOLLESON, W.H., GANGEMI, J.D., and PIRISI, L. (1993). Inhibition of growth, transformation, and expression of human papillomavirus type 16 E7 in human keratinocytes by alpha interferons. J. Virol. 67, 3396-3403.
21. PONTZER, C.H., OTT, T.L., BAZER, F.W., and JOHNSON, H.M. (1994). Structure/function studies with interferon tau: evidence for multiple active sites. J. Interferon Res. 14, 133-141.
22. PONTZER, C.H., TORRES, B.A., VALLET, J.L., BAZER, F.W., and JOHNSON, H.M. (1988). Antiviral activity of the pregnancy recognition hormone ovine trophoblast protein-1. Biochem. Biophys. Res. Commun. 152, 801-807.
23. GODKIN, J.D., BAZER, F.W., MOFFATT, J., SESSIONS, F., and ROBERTS, R.M. (1982). Purification and properties of a major, low molecular weight protein released by the trophoblast of sheep blastocyst at day 13-21. J. Reprod. Fertil. 65, 141-150.
24. OTT, T.L., VANHEEKE, G., JOHNSON, H.M., and BAZER, F.W. (1991). Cloning and expression in Saccharomyces cerevisiae of a synthetic gene for the type I trophoblast protein-1. J. Interferon Res. 11, 357-364.
25. PIRISI, L., YASUMOTO, S., FELLER, M., DONIGER, J., and DIPAOLO, J.A. (1987). Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA J. Virol. 61, 1061-1066.
26. THOMIS, D.C., FLOYD-SMITH, G., and SAMUEL, C.E. (1992). Mechanism of interferon action. cDNA structure and regulation of a novel site-specific variant of the catalytic subunit of the human protein kinase A from interferon treated human cells. J. Biol. Chem. 267, 10723-10728.
27. LIU, Y., GEORGE, C.X., PATTERSON, J.B., and SAMUEL, C.E. (1991). Functionally distinct double-stranded RNA-binding domains associated with alternative splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase. J. Biol. Chem. 272, 4419-4428.
28. TURRI, M.G., KUIN, K.A., and PORTER, A.C. (1995). Characterisation of a novel minisatellite that provides multiple splice donor sites in an interferon-induced transcript. Nucleic Acids Res. 23, 1854-1861.
29. STEPHENS, R.M., and SCHNEIDER, T.D. (1992). Features of spliceosome evolution and function inferred from an analysis of the information at human splice sites. J. Mol. Biol. 228, 1124-1136.
30. UZÉ, G., DI MARCO, S., MOUCHELE-VIELH, E., MONNERON, D., BANDU, M.T., HORISBERGER, M.A., DORQUES, A., LUTFALLA, G., and MOGENSEN, K.E. (1994). Domains of interaction between alpha interferon and its receptor components. J. Mol. Biol. 243, 245-257.
31. SENDA, T., SAITOH, S.-I., MITSUI, Y., LI. J., and ROBERTS, R.M. (1995). A three-dimensional model of interferon-τ. J. Interferon Cytokine Res. 15, 1053-1060.
32. PONTZER, C.H., BAZER, F.W., and JOHNSON, H.M. (1991). Antiproliferative activity of a pregnancy recognition hormone, ovine trophoblast protien-1. Cancer Res. 51, 5304-5307.
33. DI MARCO, S., GRÜTTER, M.G., PRIESTLE, J.P., and HORISBERGER, M.A. (1994). Mutational analysis of the structure-function relationship in interferon-α. Biochem. Biophys. Res. Commun. 202, 1445-1451.
34. UZÉ, G., BANDU, M.-T., EID, P., GRÜTTER, M., and MO GENSEN, K.E. (1988). Electrostatic interactions in the cellular dynamics of the interferon-receptor complex. Eur. J. Biochem. 171, 683-691.
35. ROBERTS, R.M., CROSS, J.C., and LEAMAN, D.W. (1992). Interferons as hormones of pregnancy. Endocrine Rev. 13, 432-452.
36. COOK, J.R., CLEARY, C.M., MARIANO, T.M., IZOTOVA, L., and PESTKA, S. (1996). Differential responsiveness of a splice variant of the human type I interferon receptor to interferons. J. Biol. Chem. 271, 13448-13453.
37. SAMUEL, C.E. (1991). Antiviral actions of interferon: interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 183, 1-11.
38. STAEHELI, P. (1990). Interferon-induced proteins and the antiviral state. Adv. Virus Res. 38, 147-200.
39. O'CONNER, M.J., TAN, S.-H., TAN, C.-H., and BERNARD, H.-U. (1996). YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity. J. Virol. 70, 6529-6539.
40. DARNELL, J.E. (1996). The Jak-Stat pathway: summary of initial studies and recent advances. Recent Prog. Horm. Res. 51, 391-404.